Herbas VPB

Print
EN | LT
LT - (Hetero)arilciklopropilamino junginiai, kaip LSD1 inhibitoriai
EN - (HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07D 213/74 (2006.01)
C07C 211/35 (2006.01)
A61K 31/135 (2006.01)
A61P 35/00 (2006.01)
A61P 31/12 (2006.01)
A61P 25/00 (2006.01)
European patent
(11) Number of the document 2776394
(13) Kind of document T
(96) European patent application number 12787388.3
Date of filing the European patent application 2012-10-22
(97) Date of publication of the European application 2014-09-17
(45) Date of publication and mention of the grant of the patent 2018-12-26
(46) Date of publication of the claims translation 2019-04-25
PCT application
(86) Number PCT/EP2012/070900
Date 2012-10-22
PCT application publication
(87) Number WO 2013/057322
Date 2013-04-25
Priority applications
(30) Number Date Country code
11382324 2011-10-20 EP
11382329 2011-10-27 EP
201161558370 P 2011-11-10 US
201161558369 P 2011-11-10 US
Inventors
(72)
ORTEGA MUŃOZ, Alberto, ES
FYFE, Matthew Colin Thor, ES
MARTINELL PEDEMONTE, Marc, ES
ESTIARTE MARTINEZ, Maria de los Angeles, ES
VALLS VIDAL, Nuria, ES
KURZ, Guido, ES
CASTRO PALOMINO LARIA, Julio Cesar, ES
Grantee
(73) Oryzon Genomics, S.A., Carrera de San Jer nimo 15, 2nd Floor, 28014 Madrid, ES
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) (Hetero)arilciklopropilamino junginiai, kaip LSD1 inhibitoriai
  (HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS
Last renewal fee
Payment date Validity (years) Amount
2024-10-11 13 289.00 EUR
Next renewal fee
2025-10-22